JP2004516329A5 - - Google Patents

Download PDF

Info

Publication number
JP2004516329A5
JP2004516329A5 JP2002552942A JP2002552942A JP2004516329A5 JP 2004516329 A5 JP2004516329 A5 JP 2004516329A5 JP 2002552942 A JP2002552942 A JP 2002552942A JP 2002552942 A JP2002552942 A JP 2002552942A JP 2004516329 A5 JP2004516329 A5 JP 2004516329A5
Authority
JP
Japan
Prior art keywords
carbon atoms
substituted
independently
alkyl
nha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002552942A
Other languages
English (en)
Japanese (ja)
Other versions
JP4550361B2 (ja
JP2004516329A (ja
Filing date
Publication date
Priority claimed from DE10064994A external-priority patent/DE10064994A1/de
Application filed filed Critical
Publication of JP2004516329A publication Critical patent/JP2004516329A/ja
Publication of JP2004516329A5 publication Critical patent/JP2004516329A5/ja
Application granted granted Critical
Publication of JP4550361B2 publication Critical patent/JP4550361B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002552942A 2000-12-23 2001-12-03 スルファミドチエノピリミジン Expired - Fee Related JP4550361B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10064994A DE10064994A1 (de) 2000-12-23 2000-12-23 Sulfamidothienopyrimidine
PCT/EP2001/014102 WO2002051848A2 (de) 2000-12-23 2001-12-03 Sulfamidothienopyrimidine zur verwendung als phosphodiesterase v-hemmer

Publications (3)

Publication Number Publication Date
JP2004516329A JP2004516329A (ja) 2004-06-03
JP2004516329A5 true JP2004516329A5 (enExample) 2009-07-23
JP4550361B2 JP4550361B2 (ja) 2010-09-22

Family

ID=7668967

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002552942A Expired - Fee Related JP4550361B2 (ja) 2000-12-23 2001-12-03 スルファミドチエノピリミジン

Country Status (19)

Country Link
US (1) US7019013B2 (enExample)
EP (1) EP1353927B1 (enExample)
JP (1) JP4550361B2 (enExample)
KR (1) KR20030062438A (enExample)
CN (1) CN1483035A (enExample)
AR (1) AR035524A1 (enExample)
AT (1) ATE302781T1 (enExample)
BR (1) BR0115996A (enExample)
CA (1) CA2432582C (enExample)
CZ (1) CZ20031815A3 (enExample)
DE (2) DE10064994A1 (enExample)
ES (1) ES2247007T3 (enExample)
HU (1) HUP0302515A3 (enExample)
MX (1) MXPA03005714A (enExample)
PL (1) PL361733A1 (enExample)
RU (1) RU2003122189A (enExample)
SK (1) SK8432003A3 (enExample)
WO (1) WO2002051848A2 (enExample)
ZA (1) ZA200305659B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101100472A (zh) * 2001-04-30 2008-01-09 美国拜尔公司 4-氨基-5,6-取代的噻吩并[2,3-d]嘧啶化合物及其应用
HRP20090395T1 (hr) * 2006-04-19 2009-08-31 Boehringer Ingelheim International Gmbh Dihidrotienpirimidini za liječenje upalnih bolesti
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
WO2008088727A2 (en) 2007-01-12 2008-07-24 Concert Pharmaceuticals, Inc. Endothelin receptor antagonists
US8080549B2 (en) * 2007-01-12 2011-12-20 Concert Pharmaceuticals, Inc. Endothelin receptor antagonists
US8093268B2 (en) 2007-01-24 2012-01-10 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2S-phenylpiperidin-3S-yl-)
EP2215093B1 (de) 2007-10-19 2011-12-14 Boehringer Ingelheim International GmbH Neue piperazino-dihydrothienopyrimidin-derivate
SI2610258T1 (sl) * 2007-10-19 2014-12-31 Boehringer Ingelheim International Gmbh Substituirani piperidino-dihidrotienopirimidini
RU2500681C2 (ru) 2007-10-19 2013-12-10 Берингер Ингельхайм Интернациональ Гмбх Замещенные гетероциклом пиперазинодигидротиенопиримидины
CN103119047B (zh) 2010-07-23 2016-06-15 哈佛大学校长及研究员协会 三环类蛋白酶体活性增强化合物
US20130059866A1 (en) 2011-08-24 2013-03-07 Boehringer Ingelheim International Gmbh Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
US9802954B2 (en) 2011-08-24 2017-10-31 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
WO2013112706A1 (en) * 2012-01-25 2013-08-01 Proteostasis Therapeutics, Inc. Proteasome activity modulating compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19644228A1 (de) * 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine
DE19752952A1 (de) * 1997-11-28 1999-06-02 Merck Patent Gmbh Thienopyrimidine
DE19819023A1 (de) * 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidine
CA2365578A1 (en) 1999-03-30 2000-10-12 Seiichi Uchida Thienopyrimidine compounds and salts thereof and process for the preparation of the same

Similar Documents

Publication Publication Date Title
JP2003531118A5 (enExample)
JP2002332234A5 (enExample)
JP2006526031A5 (enExample)
JP2023534131A5 (enExample)
JP2004535412A5 (enExample)
JP2007510619A5 (enExample)
JP2003176417A5 (enExample)
JP2007534702A5 (enExample)
JP2003528918A5 (enExample)
JP2002519425A5 (enExample)
JP2010520214A5 (enExample)
JP2002527474A5 (ja) 躁病および双極性障害の治療のための医薬
JP2005511697A5 (enExample)
JP2002513026A5 (enExample)
JP2007506721A5 (enExample)
JP2002506864A5 (enExample)
JP2004190075A5 (enExample)
JP2012518649A5 (enExample)
JP2004506769A5 (enExample)
JP2013503881A5 (enExample)
JP2005510457A5 (enExample)
JP2004506624A5 (enExample)
JP2003529598A5 (enExample)
JP2010045366A5 (enExample)
JP2006510659A5 (enExample)